Earn CME: https://naccme.com/program/7311
In this presentation from the ‘FLT3 Targets in AML: Evaluating Emerging Clinical Data and Implications on Current Practice symposium, Dr. Sanmin Lee breaks down the 500-gene mutation report for patients with acute myeloid leukemia (AML).
© 2018 Imedex, an HMP Company
Advertisement